Primary Care Use of FRAX®: Absolute Fracture Risk Assessment in Postmenopausal Women and Older Men

References

• . National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/NOF_Clinicians_Guide.pdf. Accessed October 4, 2009
   Google Scholar
• . Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr Rheumatol Rep. 2008;10(2):92–96
   PubMedGoogle Scholar
• . Tosteson AN, Melton LJ 3rd, Dawson-Hughes B,; National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19(4):437–447
   PubMed Web of Science ®Google Scholar
• . NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785–795
   PubMed Web of Science ®Google Scholar
• . World Health Organization. Summary Meeting Report. Brussels, Belgium: World Health Organization, Scientific Group on the Assessment of Osteoporosis at Primary Care Level; 2004
   Google Scholar
• . Looker AC, Orwoll ES, Johnston CC Jr,. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12(11):1761–1768
   PubMed Web of Science ®Google Scholar
• . Siris ES, Chen YT, Abbott TA,. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164(10):1108–1112
   PubMedGoogle Scholar
• . Khosla S, Melton LJ 3rd. Clinical practice. Osteopenia. N Engl J Med. 2007;356(22):2293–2300
   PubMedGoogle Scholar
• . Wainwright SA, Marshall LM, Ensrud KE,; Study of Osteoporotic Fractures Research Group. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005;90(5):2787–2793
   PubMed Web of Science ®Google Scholar
• . Pasco JA, Seeman E, Henry MJ, Merriman EN, Nicholson GC, Kotowicz MA. The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int. 2006;17(9):1404–1409
   PubMed Web of Science ®Google Scholar
• . Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: The OFELY study. J Bone Miner Res. 2005;20(10):1813–1819
   PubMed Web of Science ®Google Scholar
• . Sanders KM, Nicholson GC, Watts JJ,. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone. 2006;38(5):694–700
   PubMedGoogle Scholar
• . Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–397
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX and its applications to clinical practice. Bone. 2009;44(5):734–743
   PubMed Web of Science ®Google Scholar
• . Chen YT, Miller PD, Barrett-Connor E, Weiss TW, Sajjan SG, Siris ES. An approach for identifying postmenopausal women age 50–64 years at increased short-term risk for osteoporotic fracture. Osteoporos Int. 2007;18(9):1287–1296
   PubMedGoogle Scholar
• . Black DM, Steinbuch M, Palermo L,. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001;12(7):519–528
   PubMed Web of Science ®Google Scholar
• . Kanis JA. FRAX WHO fracture risk assessment tool. http://www.shef.ac.uk/FRAX/index.htm. Accessed June 18, 2009
   Google Scholar
• . Kanis JA. FRAX WHO fracture risk assessment tool: frequently asked questions. http://www.shef.ac.uk/FRAX/faq.htm. Accessed June 18, 2009
   Google Scholar
• . Kanis JA, Johnell O, De Laet C,. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375–382
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Borgstrom F, De Laet C,. Assessment of fracture risk. Osteoporos Int. 2005;16(6):581–589
   PubMed Web of Science ®Google Scholar
• . Siris ES, Brenneman SK, Barrett-Connor E,. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50–99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2006;17(4):565–574
   PubMedGoogle Scholar
• . Cummings SR, Cawthon PM, Ensrud KE, Cauley JA, Fink HA, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Research Groups; Study of Osteoporotic Fractures Research Groups. BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res. 2006;21(10):1550–1556
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Oden A, Johnell O,. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033–1046
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Johnell O, Oden A,. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155–162
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Johansson H, Johnell O,. Alcohol intake as a risk factor for fracture. Osteoporos Int. 2005;16(7):737–742
   PubMed Web of Science ®Google Scholar
• . Watts NB, Ettinger B, Leboff MS. FRAX facts. J Bone Miner Res. 2009;24(6):975–979
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Black D, Cooper C,; International Osteoporosis Foundation; National Osteoporosis Foundation. A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int. 2002;13(7):527–536
   PubMedGoogle Scholar
• . Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA. Lifetime risk of hip fractures is underestimated. Osteoporos Int. 1998;8(6):599–603
   PubMedGoogle Scholar
• . Dawson-Hughes B, Tosteson AN, Melton LJ 3rd,. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008;19(4):449–458
   PubMed Web of Science ®Google Scholar
• . Looker AC, Wahner HW, Dunn WL,. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8(5):468–489
   PubMed Web of Science ®Google Scholar
• . National Osteoporosis Foundation. FRAX® implementation guide released to DXA manufacturers. http://www.nof.org/news/pressreleases/20090922_FRAX_Implementation_Guide.htm. Accessed December 1, 2009
   Google Scholar
• . Kanis J. FRAX Release Notes. September 7; http://shef.ac.uk/FRAX/FRAX_Release_Notes.pdf. Accessed October 4, 2009
   Google Scholar
• . Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton LJ 3rd. Updated fracture incidence rates for the US version of FRAX®. Osteoporos Int. 2010;21(1):25–33
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Johansson H, Oden A,. A family history of fracture and fracture risk: a meta-analysis. Bone. 2004;35(5):1029–1037
   PubMed Web of Science ®Google Scholar
• . Kanis JA, Johansson H, Oden A,. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19(6):893–899
   PubMed Web of Science ®Google Scholar
• . Lewiecki EM, Watts NB. New guidelines for the prevention and treatment of osteoporosis. South Med J. 2009;102(2):175–179
   PubMedGoogle Scholar
• . Donaldson MG, Palermo L, Schousboe JT, Ensrud KE, Hochberg MC, Cummings SR. FRAX and risk of vertebral fractures: The Fracture Intervention Trial (FIT). J Bone Miner Res. 2009;24(11):1793–1799
   PubMedGoogle Scholar
• . Dargent-Molina P, Favier F, Grandjean H,. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348(9021):145–149
   PubMed Web of Science ®Google Scholar
• . Dargent-Molina P, Schott AM, Hans D,. Separate and combined value of bone mass and gait speed measurements in screening for hip fracture risk: results from the EPIDOS study. Epidémiologie de l'Ostéoporose. Osteoporos Int. 1999;9(2):188–192
   PubMedGoogle Scholar
• . Jarvinen TL, Sievanen H, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ. 2008;336(7636):124–126
   PubMedGoogle Scholar
• . Bayly J, Masud T. Preventing falls: Not at the expense of osteoporosis care. BMJ. 2008;336(7640):343
   PubMedGoogle Scholar
• . Berry SD, Samelson EJ, Hannan MT,. Second hip fracture in older men and women: the Framingham Study. Arch Intern Med. 2007;167(18):1971–1976
   PubMed Web of Science ®Google Scholar
• . Siris ES, Harris ST, Rosen CJ,. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81(8):1013–1022
   PubMed Web of Science ®Google Scholar
• . Donaldson MG, Cawthon PM, Lui LY,; Study of Osteoporotic Fractures.Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009;24(4):675–680
   PubMedGoogle Scholar
• . Dawson-Hughes B, Looker AC, Tosteson AN, Johansson H, Kanis JA, Melton LJ 3rd. The potential impact of new National Osteoporosis Foundation guidance on treatment patterns. Osteoporos Int. 2010;21(1):41–52
   PubMed Web of Science ®Google Scholar
• . McCloskey EV, Beneton M, Charlesworth D,. Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res. 2007;22(1):135–141
   PubMedGoogle Scholar
• . McCloskey EV, Johansson H, Oden A,. Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study. Osteoporos Int. 2009;20(5):811–817
   PubMed Web of Science ®Google Scholar
• . Stroup J, Kane MP, Abu-Baker AM. Teriparatide in the treatment of osteoporosis. Am J Health Syst Pharm. 2008;65(6):532–539
   PubMed Web of Science ®Google Scholar